Dec 20 2018
In 2016, more than 6,000 individuals under the age of 25 died by suicide. The majority of young people who die by suicide visit a health care provider in the month before their death, indicating that a universal screening program in medical settings could be a powerful intervention tool. An international committee of clinicians and researchers has created a 3-tiered clinical pathway system as a flexible and resource-conscious way to implement universal suicide risk screening within pediatric health care settings. To learn more about new resource, please visit the NIMH website.
Dec 13 2018
A new NIMH study of activity levels, energy levels, sleep patterns, and mood among people with depression and bipolar disorder indicates that treatments focused on increasing activity and energy levels may be more effective than treatments focused on elevating and stabilizing mood. The study combined real-time activity and sleep tracking data with participant diaries to find that activity levels affect mood, but mood does not affect activity levels – contrary to current theories of depression. For more information about this study, please visit the NIMH website.
Dec 10 2018
The FDA has granted clearance to a prescription cognitive behavioral therapy mobile phone app for people with opioid use disorder (OUD). The reSET-O app acts as a training, monitoring, and reminder tool to support patients and increase the amount of time they participate in an outpatient OUD treatment program, including buprenorphine treatment and traditional behavior therapy. To learn more about the reSET-O app, please visit the FDA website.